Influence of a novel radiopacifier on the properties of an injectable calcium phosphate cement

Acta Biomaterialia

Volumn 3, Issue 5, 2007, Pages 757-763

  Wang, Xiupeng ^a   Ye, Jiandong ^a   Wang, Yingjun ^a  

^a SOUTH CHINA UNIVERSITY OF TECHNOLOGY   (China)

Author keywords

Calcium phosphate cement; Pore distribution; Radiopacifier; Rheological properties; Strontium carbonate

Indexed keywords

CALCIUM PHOSPHATE; CARBONATION; CEMENTS; COMPRESSIVE STRENGTH;

CALCIUM PHOSPHATE CEMENT; INJECTABILITY; INJECTABLES; KYPHOPLASTY; PORES DISTRIBUTION; RADIOPACIFIERS; RHEOLOGICAL PROPERTY; VERTEBROPLASTY;

STRONTIUM COMPOUNDS;

BONE CEMENT; CALCIUM PHOSPHATE; CARBONIC ACID DERIVATIVE; STRONTIUM;

ARTICLE; COMPRESSIVE STRENGTH; FLOW KINETICS; KYPHOPLASTY; PERCUTANEOUS VERTEBROPLASTY; POWDER; PRIORITY JOURNAL;

EID: 34547680372     PISSN: 17427061     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.actbio.2007.01.004     Document Type: Article

References (34)

1. Bohner M., Gasser B., Baroud G., and Heini P. Extravasation risk factors in bone augmentation. Biomaterials 24 (2003) 2721-2730
2. Mermelstein L.E., Mclain R.F., and Yerby S.A. Reinforcement of thoracolumbar burst fractures with calcium phosphate cement. A biomechanical study. Spine 23 6 (1998) 664-670
3. Belkoff S.M., Mathis J.M., and Jasper L.E. Ex vivo biomechanical comparison of hydroxyapatite and polymethylmethacrylate cements for use with vertebroplasty. AJNR Am J Neuroradiol 23 (2002) 1647-1651
4. Baroud G., Nemes J., Ferguson S.J., and Steffen T. Material changes in osteoporotic human cancellous bone following infiltration with acrylic bone cement for a vertebral cement augmentation. Comput Methods Biomech Biomed Eng 6 (2003) 133-139
5. Hardouin P., Grados F., Cotten A., and Cortet B. Should percutaneous vertebroplasty be used to treat osteoporotic fractures? An update. Joint Bone Spine 68 (2001) 216-221
6. Mousavi P., Roth S., Finkelstein J., Cheung G., and Whyne C. Volumetric quantification of cement leakage following percutaneous vertebroplasty in metastatic and osteoporotic vertebrae. J Neurosurg: Spine 99 (2003) 56-59
7. Cotten A., Dewatre F., Cortet B., Assaker R., Leblond D., Duquesnoy B., et al. Percutaneous vertebroplasty for osteolytic metastases and myeloma: effects of the percentage of lesion filling and the leakage of methyl methacrylate at clinical follow-up. Radiology 200 (1996) 525-530
8. Jang J.S., Lee S.H., and Jung S.K. Pulmonary embolism of polymethylmethacrylate after percutaneous vertebroplasty: a report of three cases. Spine 27 (2002) 416-418
9. Padovani B., Kasriel O., Brunner P., and Peretti-Viton P. Pulmonary embolism caused by acrylic cement: a rare complication of percutaneous vertebroplasty. Am J Neuroradiol 20 (1999) 375-377
10. Nakano M., Hirano N., Matsuura K., Watanabe H., Kitagawa H., Ishihara H., et al. Percutaneous transpedicular vertebroplasty with calcium phosphate cement in the treatment of osteoporotic vertebral compression and burst fractures. J Neurosurg: Spine 97 (2002) 287-293
11. Heini P.F., Walchli B., and Berlemann U. Percutaneous transpedicular vertebroplasty with PMMA: operative technique and early results. A prospective study for the treatment of osteoporotic compression fractures. Eur Spine J 9 (2000) 445-450
12. McGraw J.K., Lippert J.A., Minkus K.D., Rami P.M., Davis T.M., and Budzik R.F. Prospective evaluation of pain relief in 100 patients undergoing percutaneous vertebroplasty: results and follow-up. J Vasc Interv Radiol 13 (2002) 883-886
13. Theodorou D.J., Theodorou S.J., Duncan T.D., Garfin S.R., and Wong W.H. Percutaneous balloon kyphoplasty for the correction of spinal deformity in painful vertebral body compression fractures. Clin Imaging 26 (2002) 1-5
14. Kuhn K.D. Bone cements: up-to-date comparison of physical and chemical properties of commercial materials (2000), Springer, Berlin
15. Vazquez B., Deb S., and Bonfield W. Optimization of benzoyl peroxide concentration in an experimental bone cement based on poly (methylmethacrylate). J Mater Sci: Mater Med 8 (1997) 455-460
16. Vila M.M., Ginebra M.P., Gil F.J., and Planell J.A. Effect of porosity and environment on the mechanical behaviour of acrylic bone cement modified with acrylonitrile-butadiene styrene particles: I Fracture toughness. J Biomed Mater Res (Appl Biomater) 48 (1999) 121-127
17. Sabokbar A., Fujikawa Y., Murray D.W., and Athanasou N. Radiopaque agents in bone cement increase bone resorption. J Bone Jt Surg [Br] 79B 22 (1997) 129-134
18. Ingham E., Green T.R., Stone M.H., Kowalski R., Watkins N., and Fisher J. Production of TNF-alpha and bone resorbing activity by macrophages in response to different types of bone cement particles. Biomaterials 21 (2000) 1005-1013
19. Wimhurst J.A., Brooks R.A., and Rushton N. The effects of particulate bone cements at the bone-implant interface. J Bone Joint Surg Br 83 (2001) 588-592
20. Khairoun I., Boltong M.G., Driessens F.C.M., and Planell J.A. Effect of calcium carbonate on clinical compliance of apatitic calcium phosphate bone cement. J Biomed Mater Res (Appl Biomater) 38 (1997) 356-360
21. Guo D.G., Xu K.W., Zhao X.Y., and Han Y. Development of a strontium-containing hydroxyapatite bone cement. Biomaterials 26 (2005) 4073-4083
22. Kanno T., Horiuchi J., and Kobayashi M. Characteristics of the carbonate ions incorporated into calcium-, partially-strontium-substituted and strontium apatites. J Mater Sci Lett 18 (1999) 1343-1345
23. Vallet-Regí M., Rámila A., Padilla S., and Muñoz B. Bioactive glasses as accelerators of apatite bioactivity. J Biomed Mater 66A (2003) 580-585
24. Saint-Jean S.J., Camiré C.L., Nevsten P., Hansen S., and Ginebra M.P. Study of the reactivity and in vitro bioactivity of Sr-substituted α-TCP cements. J Mater Sci: Mater Med 16 (2005) 993-1001
25. Kim H.W., Koh Y.H., Kong Y.M., Kang J.G., and Kim H.E. Strontium substituted calcium phosphate biphasic obtained by a powder precipitation method. J Mater Sci: Mater Med 15 (2004) 1129-1134
26. Grynpa M.D., Hamilton E., and Cheung R. Strontium increases vertebral bone volume in rats at a low dose that does not induce detectable mineralizaion defect. Bone 18 (1996) 253-258
27. Ni G.X., Lu W.W., Xu B., Chiu K.Y., Yang Z., Li Z.Y., et al. Interfacial behaviour of strontium-containing hydroxyapatite cement with cancellous and cortical bone. Biomaterials 7 (2006) 5127-5133
28. Wong C.T., Lu W.W., Chan W.K., Cheung K.M.C., Luk K.D.K., Lu D.S., et al. In vivo cancellous bone remodeling on a strontium-containing hydroxyapatite (Sr-HA) bioactive cement. J Biomed Mater 68A (2004) 513-521
29. Wang X.P., Ye J.D., and Wang H. Effects of additives on the rheological properties and injectability of a calcium phosphate bone substitute material. J Biomed Mater Res Part B: Appl Biomater 78B (2006) 259-264
30. Kjellson F., Almen T., Tanner K E., McCarthy I.D., and Lidgren L. Bone cement X-ray contrast media: a clinically relevant method of measuring their efficacy. J Biomed Mater Res Part B: Appl Biomater 70B (2004) 354-361
31. Blake G.M., Zivanovic M.A., and McEwan A.J. Sr-89 therapy strontium kinetics in metastatic bone disease. J Nucl Med 27 (1986) 1030-1035
32. Constantz B.R., Ison I.C., Fulmer M.T., Poster R.D., Smith S.T., Wagoner M.V., et al. Skeletal repair by in situ formation of the mineral phase of bone. Science 267 (1995) 1796-1799
33. Chen D.M., and Fu Y.F. Evaluation on the mechanical properties of the solid solution of strontium substituted hydroxyapatite. Chin J Stoma Mater Appar 19 (2001) 178-183
34. Liu C.S., Huang Y., and Chen J.G. The physicochemical properties of the solidification of calcium phosphate cement. J Biomed Mater Res Part B: Appl Biomater 69B (2004) 73-78